John Robert Martin, | |
2610 Enterprise Dr, Anderson, IN 46013-9684 | |
(800) 622-6575 | |
Not Available |
Full Name | John Robert Martin |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 7 Years |
Location | 2610 Enterprise Dr, Anderson, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215468079 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Vincent Anderson | Anderson, IN | Hospital |
Ascension St Vincent Fishers | Fishers, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Indiana Orthopedics Llc | 5698667822 | 142 |
News Archive
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Races around the nation are coming down to the wire Tuesday and the controversial health law continues to play a role in the campaign.
Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
News-Medical speaks to Dr. Natalia Freund about her latest research into COVID-19, and how most people are capable of producing neutralizing antibodies against the virus.
› Verified 8 days ago
Entity Name | Central Indiana Orthopedics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063422137 PECOS PAC ID: 5698667822 Enrollment ID: O20040325000156 |
News Archive
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Races around the nation are coming down to the wire Tuesday and the controversial health law continues to play a role in the campaign.
Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
News-Medical speaks to Dr. Natalia Freund about her latest research into COVID-19, and how most people are capable of producing neutralizing antibodies against the virus.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
John Robert Martin, 3600 W Bethel Ave, Muncie, IN 47304-5407 Ph: (800) 622-6575 | John Robert Martin, 2610 Enterprise Dr, Anderson, IN 46013-9684 Ph: (800) 622-6575 |
News Archive
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
Races around the nation are coming down to the wire Tuesday and the controversial health law continues to play a role in the campaign.
Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
News-Medical speaks to Dr. Natalia Freund about her latest research into COVID-19, and how most people are capable of producing neutralizing antibodies against the virus.
› Verified 8 days ago
Brian E Camilleri, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2610 Enterprise Dr, Anderson, IN 46013 Phone: 765-683-4400 | |
Dr. Brett Thomas Krepps, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3125 S Scatterfield Rd Ste 210, Anderson, IN 46013 Phone: 765-298-4311 | |
Joseph G. Jerman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2610 Enterprise Dr, Anderson, IN 46013 Phone: 765-683-4400 Fax: 765-213-3713 | |
Dr. Thomas Lawrence Salsbury, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2610 Enterprise Dr, Anderson, IN 46013 Phone: 765-683-4400 Fax: 765-642-7903 | |
Dr. Edson Drew Carrel, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2101 Jackson St, Suite 014, Anderson, IN 46016 Phone: 765-646-8272 Fax: 765-646-8547 | |
Adam Waalkes Lyon, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2610 Enterprise Dr, Anderson, IN 46013 Phone: 800-622-6575 |